Principal Investigator
Terisa
Davis
Awardee Organization
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
United States
Fiscal Year
2013
NIH RePORTER
For more information, see NIH RePORTER Project 261201200013I-0-26100005-1
Development of Muc1 Vaccine for the Prevention of Pancreatic Cancer
The objective of this Statement of Work is to assess the cancer prevention efficacy of the Muc1 vaccine alone in hMuc1.p48Cre.LSLKras G12D and p48Cre.LSL-Kras G12D mice as follows.